BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26183722)

  • 1. Higher Cardiovascular Risk in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients.
    Vieira DG; Costa-Carvalho BT; Hix S; da Silva R; Correia MSG; Sarni ROS
    Ann Nutr Metab; 2015; 66(4):237-241. PubMed ID: 26183722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
    Kimak E; Zięba B; Duma D; Solski J
    Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population.
    Yamagishi S; Adachi H; Matsui T; Nakamura K; Enomoto M; Fukami A; Otsuka M; Kumagae S; Nanjo Y; Imaizumi T
    Clin Cardiol; 2009 Sep; 32(9):E29-32. PubMed ID: 19645041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation.
    Yalcinkaya A; Unal S; Oztas Y
    Lipids Health Dis; 2019 Dec; 18(1):225. PubMed ID: 31861992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure.
    Martinelli AEM; Maranhão RC; Carvalho PO; Freitas FR; Silva BMO; Curiati MNC; Kalil Filho R; Pereira-Barretto AC
    Lipids Health Dis; 2018 Oct; 17(1):242. PubMed ID: 30342531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency.
    Macpherson ME; Halvorsen B; Yndestad A; Ueland T; Mollnes TE; Berge RK; Rashidi A; Otterdal K; Gregersen I; Kong XY; Holven KB; Aukrust P; Fevang B; Jørgensen SF
    Sci Rep; 2019 Jul; 9(1):9427. PubMed ID: 31263122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Bone Mineral Density in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients.
    Mohebbi A; Azizi G; Tavakolinia N; Abbasi F; Sayarifard F; Karimipour M; Kiaee F; Yazdani R; Ebrahimi SS; Ebrahimi M; Rafiemanesh H; Tafaroji J; Ziaee V; Abolhassani H; Aghamohammadi A
    Endocr Metab Immune Disord Drug Targets; 2017; 17(2):134-140. PubMed ID: 28606051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid transfers to HDL are diminished in long-term bedridden patients: association with low HDL-cholesterol and increased inflammatory markers.
    de Oliveira WPC; Tavoni TM; Freitas FR; Silva BMO; Maranhão RC
    Lipids; 2017 Aug; 52(8):703-709. PubMed ID: 28660528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
    Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
    Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of lipid metabolism in patients with juvenile idiopathic arthritis: relationship with disease subtype and inflammatory activity.
    Rodrigues WDR; Sarni ROS; Fonseca FLA; Araújo A; Len CA; Terreri MT
    Pediatr Rheumatol Online J; 2021 May; 19(1):66. PubMed ID: 33941215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Canola Oil Consumption on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Ghobadi S; Hassanzadeh-Rostami Z; Mohammadian F; Zare M; Faghih S
    J Am Coll Nutr; 2019 Feb; 38(2):185-196. PubMed ID: 30381009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
    Alemzadeh R; Kichler J
    Metab Syndr Relat Disord; 2018 Feb; 16(1):40-45. PubMed ID: 29154726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia.
    Marín-Echeverri C; Aristizábal JC; Gallego-Lopera N; Santa-Ramírez HA; Hoyos-Gómez M; Ruiz-Pineda AM; Arias AA; Barona-Acevedo J
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1179-1189. PubMed ID: 30367807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between lipid markers used for predicting cardiovascular risk in patients with type 2 diabetes.
    Modi KD; Chandwani R; Ahmed I; Kumar KV
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S99-S102. PubMed ID: 26589777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.